Cargando…

ADEM anti-MOG antibody-positive after SARS-CoV2 vaccination

Detalles Bibliográficos
Autores principales:	Mumoli, Laura, Vescio, Virginia, Pirritano, Domenico, Russo, Emilio, Bosco, Domenico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601784/ https://www.ncbi.nlm.nih.gov/pubmed/34796418 http://dx.doi.org/10.1007/s10072-021-05761-7

Ejemplares similares

A case of anti-MOG antibody-positive ADEM following COVID-19 mRNA vaccination
por: Miyamoto, Katsuichi, et al.
Publicado: (2022)

Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapies
por: Bellinvia, Angelo, et al.
Publicado: (2022)

ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports
por: Körtvélyessy, Peter, et al.
Publicado: (2017)

Anti-MOG antibody-positive ADEM following infectious mononucleosis due to a primary EBV infection: a case report
por: Nakamura, Yoshitsugu, et al.
Publicado: (2017)

Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity
por: Delmonte, Ottavia M., et al.
Publicado: (2021)

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
por: Reicher, Shay, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 Antibody in Healthcare Workers in Central Pennsylvania
por: Kwon, Taesung, et al.
Publicado: (2021)

Investigation of Anti-SARS-CoV-2 IgG and IgM Antibodies in the Patients with COVID-19 by Three Different ELISA Test Kits
por: Nagasawa, Masayuki, et al.
Publicado: (2020)

Clinical management of a Nigerian patient affected by sickle cell disease with rare blood group and persistent SARS‐CoV‐2 positivity
por: Quaresima, Micol, et al.
Publicado: (2020)

Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study
por: Espenhain, Laura, et al.
Publicado: (2021)

The arrival of SARS-CoV-2–neutralizing antibodies in a currently available commercial immunoglobulin
por: Miller, Aaron L., et al.
Publicado: (2022)

Diaphragmatic myoclonus due to SARS-CoV-2 infection
por: Borroni, Barbara, et al.
Publicado: (2020)

Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2
por: Ahn, Terrie S., et al.
Publicado: (2021)

Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance
por: Mariottini, Alice, et al.
Publicado: (2022)

SARS-CoV-2 vaccine-related neurological complications
por: Oonk, Nicol G. M., et al.
Publicado: (2022)

SARS-CoV-2 transmission by asymptomatic healthcare workers positive to screening swab: an Italian study
por: Palese, Francesca, et al.
Publicado: (2022)

COVID‐19 elicits an impaired antibody response against SARS‐CoV‐2 in patients with haematological malignancies
por: Passamonti, Francesco, et al.
Publicado: (2021)

Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19
por: Song, Kyoung-Ho, et al.
Publicado: (2021)

SARS-CoV-2 infection of thymus induces loss of function that correlates with disease severity
por: Rosichini, Marco, et al.
Publicado: (2023)

Vitamin D supplementation to treat SARS-CoV-2 positive patients. Evidence from meta-analysis
por: Szarpak, Luiza, et al.
Publicado: (2022)

Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
por: Cervia, Carlo, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies during the third wave of COVID-19 in the Seoul metropolitan area of Korea
por: Yoon, Kyuhyun, et al.
Publicado: (2022)

Assessment on anti-SARS-CoV-2 receptor-binding domain antibodies among CoronaVac-vaccinated Indonesian adults
por: Jo, Juandy, et al.
Publicado: (2022)

Using Anti-SARS-CoV-2 IgG and IgM Antibodies to Detect Outpatient Cases with Olfactory and Taste Disorders Suspected as Mild Form of COVID-19: a Retrospective Survey
por: Taziki Balajelini, Mohammad Hosein, et al.
Publicado: (2020)

Seroprevalence of SARS-CoV-2 antibodies in the community based on participants in the 2020 Korea National Health and Nutrition Examination Survey
por: Kim, Ah-Ra, et al.
Publicado: (2022)

Prevalence and risk factors of SARS-CoV-2 antibody responses among healthcare workers (June 2020–November 2021)
por: Barrufet, Maria Pilar, et al.
Publicado: (2023)

Isolated musculocutaneous involvement in neuralgic amyotrophy associated with SARS-CoV2 vaccination
por: Civardi, Carlo, et al.
Publicado: (2022)

Does Every Patient with a Positive SARS-CoV-2 RT-PCR Test Require Isolation? A Prospective Analysis
por: Rhee, Chanu, et al.
Publicado: (2021)

New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report
por: Dono, Fedele, et al.
Publicado: (2020)

Air filtration and SARS-CoV-2
por: Nazarenko, Yevgen
Publicado: (2020)

Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
por: Alshebri, Munirah Saad, et al.
Publicado: (2020)

Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination
por: Kwon, Hyeryung, et al.
Publicado: (2021)

Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events
por: Ng, Siew C, et al.
Publicado: (2022)

COVID-19 Vaccination Associated With Reduced Postoperative SARS-CoV-2 Infection and Morbidity
por: Prasad, Nikhil K., et al.
Publicado: (2022)

Safety of SARS-CoV-2 vaccines in patients with myasthenia gravis: a meta-analysis
por: Zheng, Qian, et al.
Publicado: (2023)

Management and Prevention of Cerebrovascular Accidents in SARS-CoV-2–Positive Patients Recovering from COVID-19: a Case Report and Review of Literature
por: Yeganegi, Masoud, et al.
Publicado: (2021)

Low infectivity among asymptomatic patients with a positive SARS-CoV-2 admission test at a tertiary-care center, 2020–2022
por: Tayyar, Ralph, et al.
Publicado: (2023)

Simultaneous analysis of antigen‐specific B and T cells after SARS‐CoV‐2 infection and vaccination
por: Newell, Krista L., et al.
Publicado: (2022)

New daily persistent headache after SARS-CoV-2 infection: a report of two cases
por: Dono, Fedele, et al.
Publicado: (2021)

Antidiabetes Agents against Sars-Cov-2 Infection
por: Vitiello, Antonio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2tla2latjffqmahetf2s15pg3h